首页> 外文期刊>Journal of Investigative Medicine High Impact Case Reports >A Rare Case of a Transgender Female With Breast Implant–Associated Anaplastic Large Cell Lymphoma Treated With Radiotherapy and a Review of the Literature
【24h】

A Rare Case of a Transgender Female With Breast Implant–Associated Anaplastic Large Cell Lymphoma Treated With Radiotherapy and a Review of the Literature

机译:少见的变性女性乳房放疗相关的间变性大细胞淋巴瘤放疗治疗及文献复习

获取原文
       

摘要

We are reporting a case of a 54-year-old transgender female with a history of breast augmentation with bilateral silicone implants. Seventeen years later, she presented with an enlarging right breast mass. Pathology confirmed breast implant–associated anaplastic large cell lymphoma (Ann Arbor Stage IIE, TNM Stage III BIA-ALCL). The patient underwent bilateral capsulectomy, sentinel lymph node biopsy with adjuvant CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) chemotherapy, and radiotherapy to the right chest, axilla, and supraclavicular lymph nodes. BIA-ALCL is a rare entity, especially in transgender females. We report this case and a review of the literature in this report.
机译:我们正在报告一例54岁的变性女性,有双侧硅胶植入物隆胸的历史。十七年后,她的乳房增大。病理证实了与乳房植入物相关的间变性大细胞淋巴瘤(Ann Arbor IIE期,TNM III期BIA-ALCL)。该患者接受了双侧小肠切开术,前哨淋巴结活检和辅助CHOP(环磷酰胺,阿霉素,长春新碱和泼尼松)化疗,并对右胸,腋窝和锁骨上淋巴结进行了放疗。 BIA-ALCL是一种罕见的实体,尤其是在跨性别女性中。我们报告了这种情况,并在此报告中对文献进行了回顾。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号